...Hsuan-Chieh Lin; Yong-Chen Huang; Yi-Ting Hsieh; Shu-Hui Chang Introduction: This study evaluated the effect of panretinal photocoagulation (PRP) or combined both anti-VEGF therapy and PRP in proliferative diabetic retinopathy (PDR) on the risk of diabetic macular edema (DME) or vitreous hemorrhage...

... were secondary endpoints. Results: Across 13 studies, in the context of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), 2,226 eyes received anti-VEGF monotherapy and 3,022 received faricimab. Final and change in BCVA were similar...

.... 2024 Retinal thickness fluctuation Visual acuity Anti-vascular endothelial growth factor Age-related macular degeneration Retinal vein occlusion Diabetic macular edema Anti-vascular endothelial growth factor (anti-VEGF) therapy is indicated in several conditions, including...

...Andrew Mihalache; Amin Hatamnejad; Nikhil S. Patil; Marko M. Popovic; Peter J. Kertes; Miguel Cruz-Pimentel; Rajeev H. Muni Background: The comparative safety and efficacy of different doses of intravitreal triamcinolone acetonide (IVTA) for diabetic macular edema (DME) and macular edema (ME...

... for the treatment of diabetic macular edema (DME). Methods: This retrospective analysis of an open-label, multicenter, consecutive case series included 130 eyes of 65 patients with bilateral DME who were treated with intravitreal DEX implants. The patients were divided into two groups: a control group (comprising...

...Jean-François Korobelnik; David Gaucher; Stéphanie Baillif; Catherine Creuzot-Garcher; Laurent Kodjikian; Michel Weber Introduction: Central vision loss due to diabetic macular edema (DME) is related to the macular edema itself but also, in some cases, to alterations of the foveal avascular zone...

... treated diabetic macular edema (DME) patients. Methods: A multicenter, retrospective study of DME patients, previously treated with anti-VEGF injections, who were followed up during COVID-19 pandemic (2020) compared to pre-CO­VID-19 period (2019). Results: A total of 634 DME patients with a mean age...

... in detecting retinal fluid in spectral-domain OCT volume scans from a large cohort of patients with neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME). Methods: A total of 3,981 OCT volumes from 374 patients with AMD and 11,501 OCT volumes from 811 patients with DME were...

...Gulsah Gumus; Gurkan Erdogan; Betul Onal Gunay; Gonul Karatas Durusoy Introduction: The aim of this study was to compare posterior subtenon triamcinolone (PSTA) application and intravitreal dexamethasone phosphate (DEX) implant in the treatment of diabetic macular edema (DME) in vitrectomized eyes...

... in diabetes retinopathy patients with and without diabetic macular edema (DME). Methods: A retrospective interventional case series of consecutive patients who underwent PPV with ERM peeling. Patients were divided into two groups: those with and without preoperative DME. Visual acuity (VA) and optical...

...Dante Akira Kondo Kuroiwa; Fernando Korn Malerbi; Caio Vinicius Saito Regatieri Diabetic macular edema (DME) is the most common cause of vision loss in diabetic eyes, and due to the rapid rise in the number of diabetic patients, the treatment burden has increased exponentially. The introduction...

...Betul Onal Gunay; Gurkan Erdogan Aim: To evaluate long-term macular changes following pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling for diabetic macular edema (DME). Methods: Forty eligible eyes of 37 patients were included in this retrospective study. Best corrected...

...: 4.5–5.3%). Among the subjects with ocular complications, 1.8% had proliferative diabetic retinopathy, 1.1% had diabetic macular edema (DME), 0.3% had neovascular glaucoma, and 1.5% had vitreous hemorrhage. Only DME significantly increased during the study period. The frequencies of the ocular...

...Francesco Bandello; Maria Vittoria Cicinelli In the last decades, significant changes have been taking place regarding the pathogenesis of diabetic retinopathy (DR) and the complex mechanisms that eventually lead to the various manifestations of the disease, including diabetic macular edema (DME...

...Marc Figueras-Roca; Marta S. Figueroa; Pilar Calvo; Gonzaga Garay-Aramburu; Jesús R. García-Martínez; Ana María Fernández; Aránzazu Pou; Alfredo Adán; the EMUREX Study Group Purpose: To define and develop a model of excellence for the clinical management of diabetic macular edema (DME) patients...

...Kang Yeun Pak; Jae Pil Shin; Hyun Woong Kim; Min Sagong; Yu Cheol Kim; Sang Joon Lee; In Young Chung; Sung Who Park; Ji Eun Lee Introduction: The purpose of this study was to report the one-year results of treatment of diabetic macular edema (DME) with aflibercept using a treat-and-extend regimen...

...Manuel Falcão Purpose: Evaluation of the impact of the injection frequency of ranibizumab on best-corrected visual acuity (BCVA) outcomes in patients with diabetic macular edema (DME). Methods: A meta-analysis of randomized controlled trials (RCTs) and real-world studies was performed to quantify...

...Zubir S. Rentiya; Saleema Kherani; Bushra Usmani; Manneha A. Qazi; Mohammad Ali Sadiq; Mustafa Iftikhar; Quan Dong Nguyen; Syed M. Shah; Yasir J. Sepah; on behalf of the Read-3 study group Purpose: To evaluate the thickness of individual retinal layers in eyes with resolved diabetic macular edema...

...Daniele De Geronimo; Paola Giorno; Fabio Scarinci; Antonluca Boninfante; Monica Varano; Mariacristina Parravano Objective: To gain information about multiple dexamethasone intravitreal implant (DEX-I) injections in diabetic macular edema (DME) eyes in real-life clinical settings. Methods: Patients...

...Petra Schwarzer; Andreas Ebneter; Marion Munk; Sebastian Wolf; Martin S. Zinkernagel Purpose: To evaluate real-life outcomes in treatment-naive patients with diabetic macular edema (DME) treated with anti-vascular endothelial growth factor (VEGF) agents using a treat-and-extend regimen without...